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The transcription factor HIF1A is a key mediator of
the cellular response to hypoxia. Despite the impor-
tance of HIF1A in homeostasis and various pathol-
ogies, little is known about how it regulates RNA
polymerase II (RNAPII). We report here that HIF1A
employs a specific variant of the Mediator complex
to stimulate RNAPII elongation. The Mediator-asso-
ciated kinase CDK8, but not the paralog CDK19, is
required for induction of many HIF1A target genes.
HIF1A induces binding of CDK8-Mediator and the
super elongation complex (SEC), containing AFF4
and CDK9, to alleviate RNAPII pausing. CDK8 is
dispensable for HIF1A chromatin binding and his-
tone acetylation, but it is essential for binding of
SEC and RNAPII elongation. Global analysis of active
RNAPII reveals that hypoxia-inducible genes are
paused and active prior to their induction. Our results
provide amechanistic link betweenHIF1A andCDK8,
two potent oncogenes, in the cellular response to
hypoxia.
INTRODUCTION
Hypoxia is a hallmark of rapidly growing tissues such as devel-
oping embryos and solid tumors. The cellular response to hypox-
ic stress involves the activation of hypoxia-inducible factors
(HIFs), a group of DNA-binding proteins that induce transcription
of numerous genes involved in angiogenesis, glycolysis, meta-
bolic adaptation, erythropoiesis, and cell survival (Semenza,
2012). Accordingly, the transcriptional response to hypoxia is
essential for both proper embryonic development and growth
of many solid tumors (Ryan et al., 1998). HIFs are heterodimerictranscription factors composed of a and b subunits (Wang et al.,
1995). Whereas b subunits (ARNT1-3) are expressed constitu-
tively, the expression of a subunits (HIF1A, HIF2A, and HIF3A)
is tightly regulated at the level of protein turnover by an oxy-
gen-sensing pathway. In normoxia, enzymatic hydroxylation of
key asparagine and proline residues in the a subunits inhibits
their transactivation potential and generates a binding surface
for the E3 ubiquitin ligase VHL (von Hippel-Lindau tumor sup-
pressor), which triggers their degradation by the proteasome
(Ivan et al., 2001; Jaakkola et al., 2001). Hydroxylation is
impaired during hypoxia, leading to stabilization of a subunits,
their nuclear accumulation, heterodimerization with b subunits,
and consequent activation of target genes.
Although the biological importance of HIFs is undisputed,
relatively little is known about the molecular mechanisms by
which they control RNA polymerase II (RNAPII). Overexpression
of HIF1A is known to drive the progression of various cancers,
likely due to the adaptive advantage conferred by increased
expression of target genes such as those encoding glycolytic
enzymes (PGK, LDHA), proangiogenic factors (VEGF), and
glucose transporters (GLUT1). Recently, HIF1A was implicated
in the development of dietary obesity, atherosclerosis, pulmo-
nary hypertension, and abdominal aortic aneurysm formation
(Semenza, 2012). Thus, a detailed understanding of HIF1A-
dependent RNAPII transactivation will impact diverse fields of
biomedical research. Much effort has been devoted to the char-
acterization of the HIF proteins and the DNA elements they
recognize (Mole et al., 2009), but little is known about HIF coac-
tivators. The HIF-a subunits contain an N-terminal transactiva-
tion domain (N-TAD) that overlaps the oxygen-dependent
degradation domain and a C-terminal transactivation domain
(C-TAD) that contains a conserved asparagine whose hydroxyl-
ation impairs binding to the coactivators CBP and p300 (Kallio
et al., 1998). These two lysine acetyl-transferases are often de-
picted as the key HIF coactivators, and, recently, PKM2 was
identified as a cofactor enhancing HIF1A binding and p300Cell 153, 1327–1339, June 6, 2013 ª2013 Elsevier Inc. 1327
recruitment to hypoxia response elements (Luo et al., 2011).
However, mutation of the CBP/p300 CH1 domain that is
required for HIF interaction impairs expression of only a minority
of HIF target genes, revealing the existence of additional coac-
tivators (Kasper et al., 2005).
The Mediator coactivator complex is a widespread regulator
of RNAPII activity conserved from yeast to humans (Bourbon,
2008; Conaway and Conaway, 2011). Since its early identifica-
tion and characterization in yeast (Koleske et al., 1992; Thomp-
son et al., 1993), Mediator has been shown to interact with
RNAPII, general transcription factors, diverse DNA-binding
proteins, transcription elongation factors, and chromatin archi-
tecture proteins, thus serving as a signaling hub capable of inte-
grating multiple inputs for precise control of RNAPII (Malik and
Roeder, 2010). In mammals, Mediator is composed of 25–30
subunits assembled into distinct modules. The exact subunit
composition of Mediator is variable, which may provide a mech-
anism for increased regulatory diversity and specificity (Sato
et al., 2004). The CDK module of Mediator carries the only
known enzymatic activity in the complex and associates with
the rest of Mediator in a facultative fashion (Sato et al., 2004).
Although the CDK module was initially characterized as a
repressor, recent work has shown that it is also required for
gene activation across multiple transcriptional programs (for
review, see Galbraith et al., 2010). Intriguingly, three subunits
of this module have undergone gene duplications in the verte-
brate lineage to generate the paralogous pairs CDK8/CDK19,
MED12/MED12L, and MED13/MED13L (Sato et al., 2004).
Although very little is known about the functions of the different
paralogs, it is expected that they each have specialized
roles in mammals. For example, CDK8, but not CDK19, has
been defined as an oncogene in colorectal cancer (Firestein
et al., 2008).
In order to define specific functions for CDK8, we performed a
comparative analysis of the two kinases in colorectal cancer
cells. We found that they assemble into mutually exclusive Medi-
ator complexes and regulate unique transcriptional programs.
Strikingly, we found that CDK8, but not CDK19, is required for
induction of many HIF1A target genes. Mechanistic studies
revealed the existence of a HIF1A-dependent coactivation event
acting in addition to HIF1A-induced histone acetylation. We
found that HIF1A induces binding of CDK8 to its target genes
during hypoxia and that its activation domain interacts with
CDK8-Mediator. Prior to induction, hypoxia-inducible genes
carry transcriptionally engaged, proximally paused RNAPII.
Increased histone acetylation and recruitment of the BRD4 pro-
tein upon HIF1A activation does not suffice to activate paused
RNAPII at these genes. Instead, we demonstrate that HIF1A
employs CDK8-Mediator to recruit the super elongation complex
(SEC) along with CDK9. Global analysis of active RNA polymer-
ases revealed that nearly all HIF1A targets are actively tran-
scribed but display pausing during normoxia, suggesting that
the transition to elongation is rate limiting and fitting with the
notion that CDK8 helps to stimulate pause release. Thus, our
studies constitute a significant advance in our understanding
of how HIF1A and CDK8 regulate transcription and reveal a
molecular mechanism by which these two oncogenes can
collaborate.1328 Cell 153, 1327–1339, June 6, 2013 ª2013 Elsevier Inc.RESULTS
CDK8 Regulates Gene Expression Programs Distinct
from CDK19
CDK8 and CDK19 are paralogous kinases previously found to
associate with the Mediator complex (Figure S1A available
online) (Sato et al., 2004). Using quantitative RT-PCR (qRT-PCR),
we observed wide coexpression of the two kinases across
normal tissues, with a few sites showing higher expression for
CDK8 (e.g., bladder, esophagus) or CDK19 (e.g., brain) (Fig-
ure S1B). Coexpression is also evident at the protein level in
cell lines of diverse origins (Figure S1C). To investigate the
possible functional specialization of CDK8 in colorectal cancer
cells, we employed the well-characterized HCT116 cell line,
which expresses significant amounts of both proteins (Fig-
ure S1D). Affinity complex purification of HaloTag versions of
CDK8 and CDK19 revealed that the two kinases exist in mutually
exclusive variants of Mediator, as CDK19 is undetectable in
CDK8 complexes or vice versa (Figure 1A). Importantly, both
kinases assemble with the rest of the CDK module and core
Mediator carrying MED26, a subunit shown to interact with the
SEC containing CDK9 (Takahashi et al., 2011), which is also
detected in both complexes.
With the goal of identifying gene expression networks
controlled preferentially by CDK8, we performed a series of
microarray analyses in HCT116 colorectal cancer cells where
either kinase was stably knocked down (Figures S1D and
1B–1E; Table S1). First, we analyzed the effects on global
gene expression under conditions that lead to exponential cell
proliferation (Figure 1B). Importantly, the gene sets affected
by each kinase are largely nonoverlapping, revealing a special-
ization for each kinase in gene expression control. Of note, a
greater number of genes are significantly induced or repressed
by CDK8 knockdown than by CDK19 knockdown, indicating
that CDK8 is a more widespread regulator of gene expression
under these conditions in HCT116 cells. Next, we analyzed
the impact of each kinase on stimulus-specific gene expression
programs. Toward this end, we subjected HCT116 cells to three
different stress stimuli: 5-fluorouracil (5FU), which provokes a
genotoxic stress response involving p53 and other transcription
factors; glucose deprivation, which affects gene expression
programs downstream of AMPK and mTOR pathways; and
hypoxia, which activates adaptive pathways, including those
regulated by HIF1A and HIF2A (Figures 1C–1E). In contrast to
what is evident during exponential cell proliferation, CDK19
knockdown has a more pronounced effect than CDK8 depletion
on the gene expression programs elicited by genotoxic stress
and glucose deprivation. This indicates that the minor effects
of CDK19 knockdown seen under standard culture conditions
are not due to poor knockdown, but rather to a functional
specialization of this kinase. Most strikingly, many more hypox-
ia-inducible genes show a requirement for CDK8 than for
CDK19. Of 317 genes significantly induced by hypoxia, 207
(65%) showed reduced expression in CDK8-depleted cells,
whereas only 39 (13%) showed reduced expression upon
CDK19 knockdown.
These data demonstrate that theMediator-associated kinases
CDK8 and CDK19 have specialized to regulate different gene
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Figure 1. CDK8 and CDK19 Regulate Distinct Gene Expression Programs
(A) Western blots showing mutually exclusive interaction of CDK8 and CDK19 with the CDKmodule of Mediator. CDK-module subunits (CDK8, CDK19, Cyclin C,
MED12, and MED13), MED26, and CDK9 were detected in pull-downs from protein extracts of HCT116 cells expressing HaloTag (HT) alone, HT-CDK8, or
HT-CDK19. Increasing 2-fold dilutions are shown to indicate relative abundance of interacting subunits.
(B)Microarray analysis showing the effects of CDK8 (shCDK8) or CDK19 (shCDK19) knockdown on the gene expression profiles of HCT116 cells under conditions
leading to exponential cell proliferation, sorted by effect of shCDK8 or shCDK19 (>1.5-fold change from shControl, p < 0.05).
(C–E) Microarray analysis showing the effects of CDK8 or CDK19 knockdown on genes induced by (C) genotoxic stress upon 5-fluorouracil treatment (5FU, 12 hr),
(D) by glucose deprivation (24 hr), or (E) by hypoxia (1%O2, 24 hr). In all cases, induction is defined as >1.5-fold, p < 0.05. Heatmaps are color-coded by log2 fold
change, treated versus untreated shControl cells for induction, shCDK8 or shCDK19 treated versus shControl treated for knockdown effect. Venn diagrams
compare the numbers of genes induced by each stimuli to those decreased by shCDK8 and shCDK19 under each condition (R1.1-fold change, p < 0.05).
See also Figure S1 and Table S1.expression programs, with a predominant role for CDK8 in pos-
itive control of hypoxia-inducible genes.
CDK8 Is Widely Required for Activation of HIF1A Target
Genes
Because CDK8 knockdown leads to reduced expression of hyp-
oxia-inducible genes, we hypothesized that CDK8 functions as a
coactivator for HIF1A. To test this, we used qRT-PCR to monitor
the impact of CDK8 knockdown or HIF1A knockout on the
expression of hypoxia-inducible genes that were affected by
CDK8 knockdown according to our microarray analysis. Expect-edly, qRT-PCR confirmed the requirement for CDK8 for full
induction of all ten genes selected (ANKRD37 through CITED2,
Figure 2A). For contrast purposes, we included TMEM45A and
CXCR4, two genes that do not require CDK8. Importantly,
HIF1A is also required for induction of most of this set of genes,
with DUSP5 and CITED2 being the only exceptions (Figure 2B).
Thus, CDK8 can coregulate HIF1A target genes in HCT116 cells.
Knockdown of CDK8 has no effect on the stabilization of HIF1A
or HIF2A upon hypoxia (Figure S2A), suggesting that CDK8 acts
at downstream steps in the hypoxic response. Furthermore,
CDK8 depletion has minimal impact on the basal expression ofCell 153, 1327–1339, June 6, 2013 ª2013 Elsevier Inc. 1329
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Figure 2. CDK8 Is a Coactivator of Many Hypoxia-Inducible Genes
(A) Relative expression of hypoxia-inducible genes as measured by qRT-PCR for control and CDK8 knockdown HCT116 cells in normoxia or after 24 hr hypoxia
(1% O2). Expression values were normalized to 18S ribosomal RNA (rRNA) and are expressed relative to the control normoxia value. Error bars represent SEM
from three independent biological replicates.
(B) Relative expression of hypoxia-inducible genes asmeasured by qRT-PCR for HIF1A+/+ and HIF1A/HCT116 cells in normoxia or after 24 hr hypoxia (1%O2).
(C) Venn diagrams displaying the proportion of hypoxia-inducible genes with CDK8 peaks and those negatively affected by CDK8 knockdown in normoxia and
hypoxia.
(D) CDK8 binding profiles around transcription start sites in normoxia and hypoxia as determined by ChIP-seq. Shown are 10 kb regions centered on all unique
RefSeq TSS (left) and the TSS of hypoxia-inducible genes (right). Heatmaps are ranked by the CDK8 normoxia signal, and the color scale represents tags
per 50 bp.
(E) Metagenes centered on TSS showing CDK8 binding profiles for RefSeq genes (top) and hypoxia-inducible genes (bottom) in normoxia (blue) and hypoxia (red).
(F) Dot plot comparing CDK8 enrichment in normoxia (x axis) and hypoxia (y axis) at all CDK8 peak regions (blue) and at peaks associated with hypoxia-inducible
genes (red). The gray line represents a 1:1 relationship (no change) between normoxia and hypoxia.
(G) Genome browser views of CDK8 binding at HIF1A target loci under both normoxic (gray) and hypoxic conditions (black).
See also Figure S2 and Table S2.most of these genes during normoxia (Figure S2B). CDK8 knock-
down using a different short hairpin RNA (shRNA) also impaired
induction of HIF1A target genes (Figures S2C and S2D).
To test whether CDK8 could be acting directly at HIF1A target
genes on a global scale, we performed CDK8 chromatin immu-
noprecipitation sequencing (ChIP-seq) experiments in HCT116
cells under normoxic and hypoxic conditions. This global anal-
ysis of CDK8 chromatin binding revealed that 43% of CDK81330 Cell 153, 1327–1339, June 6, 2013 ª2013 Elsevier Inc.peaks are found within the region spanning 3 kb upstream of
transcription start sites (TSSs) through to 50 UTRs, whereas
another 50% are found in more distal intergenic and intragenic
regions (Figure S2E). During normoxia, although 74% (235/317)
of hypoxia-inducible genes are associated with significant
CDK8 peaks, only 5% (12/235) of these display reduced basal
expression in shCDK8 cells, suggesting that CDK8 is important
mostly for their induced expression. Upon hypoxia, 64%
(204/317) of hypoxia-inducible genes were associated with
significant CDK8 peaks, and the expression of roughly 70%
(137/204) of these genes is negatively affected by CDK8 knock-
down (Figure 2C; Table S2).
When analyzed in a 10 kb window around TSSs, a gradient of
CDK8 occupancy becomes apparent both at all RefSeq genes
and at hypoxia-inducible genes, with maximum signals centered
over TSSs (Figures 2D–2E). Further analysis reveals that hypox-
ia-inducible genes have a significantly higher level of CDK8 bind-
ing at their TSSs and also display more spreading of CDK8 into
the gene body, as compared to the global average (Figures 2E
and S2F). Interestingly, hypoxia leads to a general decrease of
CDK8 binding throughout the genome, concurrently with equal
or increased CDK8 binding at peaks associated with hypoxia-
inducible genes (Figure 2F). This is also apparent when looking
at TSSs and 30 ends of genes (Figures S2G and S2H). Thus,
although hypoxia does not affect overall CDK8 protein expres-
sion (Figures S2A and S2C), it does produce a global change
toward binding at the genes upregulated in this scenario. Repre-
sentative examples of this pattern of CDK8 binding are shown for
the HIF1A target genes ANKRD37 and ALDOC in Figure 2G.
CDK8 Regulates RNAPII Elongation without Affecting
HIF1A Binding or Histone Acetylation
To investigate the mechanism by which CDK8 contributes to
expression of HIF1A target genes, we performed a detailed
quantitative ChIP analysis of the ANKRD37 and STC2 gene loci
(Figures 3 and S3, respectively). Both genes undergo robust
HIF1A- and CDK8-dependent induction upon hypoxia but are
not affected by CDK19 depletion (Figure S3A). As predicted
from our ChIP-seq analysis, CDK8 is recruited to the ANKRD37
locus upon hypoxia, with peak signals around the TSS (Fig-
ure 3A). Expectedly, CDK8 ChIP signals are much reduced in
shCDK8 cells. Interestingly, total RNAPII shows significant
enrichment at the TSS under normoxia, when expression of
ANKRD37mRNA is 50- to 100-fold lower (Figure 3B). Upon hyp-
oxia, a modest increase (<2-fold) in RNAPII is observed at the
promoter, but a much more significant increase (up to 20-fold)
in RNAPII occupancy is observed at the intragenic and 30
regions. This RNAPII behavior is indicative of transcriptional
pausing and is observed at many genes induced in response
to specific stimuli (Boehm et al., 2003; Core and Lis, 2008;
Rahl et al., 2010). Conversion of paused RNAPII into an elonga-
tion competent form involves the action of diverse elongation
factors as well as various phosphorylation events, including
phosphorylation of the C-terminal domain (CTD) heptad repeats
of the RPB1 subunit of RNAPII. ChIP analysis of Ser5- and Ser2-
phospho-CTD (S5P, S2P) revealed a significant increase in both
phosphorylation events upon hypoxia (Figures 3C and 3D). In
agreement with the typical patterns of these two phosphoryla-
tion marks, S5P peaks toward the 50 end, whereas S2P is higher
within the gene body and at the 30 end. Importantly, CDK8
depletion leads to a substantial decrease in both total and
phospho-RNAPII within the gene body of ANKRD37 (Figures
3B–3D). Similar results were observed at the STC2 locus (Fig-
ure S3B). Taken together, this indicates that CDK8 is a positive
regulator of RNAPII activity at these HIF1A target genes, likely
acting to promote RNAPII elongation.Upon hypoxia, HIF1A hydroxylation is impaired, which leads to
increased HIF1A levels and enhanced association of the HIF1A
C-TAD with p300/CBP (Kallio et al., 1998). Expectedly, ChIP
analysis revealed a strong increase in HIF1A occupancy and
acetylation of histones H3 and H4 upon hypoxia at the ANKRD37
and STC2 loci (Figures 3E–3G and S3B). Importantly, CDK8
depletion does not affect HIF1A chromatin binding or histone
acetylation. In fact, CDK8 knockdown leads to a modest
increase in HIF1A binding and histone H4 acetylation at the
STC2 locus (Figure S3B). This demonstrates that HIF1A binding
and the subsequent increase in histone acetylation are not suffi-
cient to fully activate RNAPII, thus revealing the existence of an
additional, previously unappreciated coactivation event
involving CDK8 at these genes.
CDK8 Is Required for Recruitment of the Super
Elongation Complex
Given the fact that CDK8 depletion impairs RNAPII phosphoryla-
tion and elongation at HIF1A target loci, we next investigated its
role in recruitment of P-TEFb (positive transcription elongation
factor b), a critical regulator of RNAPII elongation. CDK9, the cat-
alytic subunit of P-TEFb, overcomes RNAPII pausing in a kinase-
dependent manner likely by phosphorylating various targets
such as the negative elongation factor NELF, as well as RNAPII
itself (Peterlin and Price, 2006). CDK9 recruitment to the
ANKRD37 and STC2 loci is strongly stimulated by hypoxia but,
importantly, is much reduced in CDK8 knockdown cells (Figures
3H and S3B). Numerous mechanisms have been described to
explain P-TEFb binding to promoters during gene activation
including recruitment by DNA-binding transactivators such as
MYC (Rahl et al., 2010), recruitment by BRD4, a bromodomain
protein that recognizes acetylated histones (Jang et al., 2005;
Yang et al., 2005), and also by association withMediator (Donner
et al., 2010; Takahashi et al., 2011). Importantly, a fraction of
P-TEFb exists within the so-called SEC containing the scaffold
protein AFF4, which interacts directly with MED26 (Lin et al.,
2010; Takahashi et al., 2011). To investigate which of these
P-TEFb recruitment mechanisms could be operating at HIF1A
target genes, we performed ChIP analysis of BRD4, AFF4, and
the core Mediator subunits MED1 and MED26 (Figures 3I–3L).
Hypoxia induces strong recruitment of BRD4, AFF4, MED1,
and MED26 to ANKRD37, whereas CDK8 depletion modestly
impairs BRD4 binding but completely abolishes AFF4 recruit-
ment (Figures 3I and 3J). Interestingly, recruitment of the Medi-
ator subunits MED1 and MED26 is also significantly reduced
upon CDK8 knockdown, suggesting that the kinase subunit is
required for full association of core Mediator (Figures 3K
and 3L). Of note, CDK8 depletion also reduced the intragenic
levels of the Spt5 subunit of DSIF, a factor that promotes
RNAPII elongation after its phosphorylation by P-TEFb (Peterlin
and Price, 2006) (Figure 3M). For contrast purposes, we show
that induced recruitment of CDK7, the kinase subunit of the gen-
eral transcription factor TFIIH, is not affected by CDK8 knock-
down, indicating that preinitiation complex (PIC) formation is
not impaired (Figure 3N). Overall, the data indicate that CDK8
coactivates HIF1A targets by mediating recruitment of P-TEFb
and the SEC, perhaps via MED26, downstream or independently
of histone acetylation and BRD4.Cell 153, 1327–1339, June 6, 2013 ª2013 Elsevier Inc. 1331
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Figure 4. HIF1A Is Required for Recruitment of CDK8, Mediator, and P-TEFb to Chromatin
(A) Quantitative ChIP analysis of total RNAPII, serine-5, and serine-2-phosphorylated RNAPII CTD (S5P, S2P), histone acetylation (H3K9ac and H4ac), CDK8,
MED1, and CDK9 at the ANKRD37 locus in HIF1A+/+ and HIF1A/ cells. Values are plotted as a percentage of the maximum signal. Error bars represent SEM
from three independent biological replicates. Gray shading indicates the transcribed region.
(B) Schematic of HIF1A protein domains cloned as GST fusions for use as affinity bait proteins.
(C) Western blot analysis of proteins purified by their affinity for GST-HIF1A or GST-VP16 transactivation domains. GST alone served as a negative control.
VP16-interacting proteins were diluted 10-fold lower to avoid overloading.
See also Figure S4.We next tested the effect of CDK8 knockdown on induction of
the key HIF1A targets ANKRD37 and ALDOC in cancer cell lines
of different origin and found a similar requirement for CDK8 (Fig-
ure S3C). We also carried out ChIP analysis of the ANKRD37
locus in U2OS osteosarcoma cells and found that, as for
HCT116 cells, CDK8 knockdown impaired RNAPII elongation
andCDK9 recruitment without affecting HIF1A binding or histone
acetylation (Figures S3D and S3E).
HIF1A Induces Recruitment of CDK8-Mediator
and P-TEFb to Chromatin
The data shown so far indicate that CDK8 is required at steps
subsequent to HIF1A binding and histone acetylation and ledFigure 3. CDK8 Regulates RNAPII Elongation without Affecting HIF1A
(A–N) Quantitative ChIP analysis of (A) CDK8, (B) total RNAPII, (C) serine-5-, and (D
(G) H4ac histone acetylation, (H) the CDK9 subunit of P-TEFb, (I) the bromodomain
and (L) MED26, (M) the DSIF subunit Spt5, and (N) the TFIIH subunit CDK7 at the
after 24 hr hypoxia (1% O2).
Values are plotted as a percentage of the maximum signal for that locus. Error b
indicates the transcribed region. See also Figure S3.us to hypothesize that HIF1A might recruit CDK8-Mediator to
facilitate RNAPII elongation. To test this, we performed ChIP
assays in HCT116 HIF1A+/+ versus HIF1A/ cells (Figure 4A).
Strikingly, large amounts of RNAPII are detected at the
ANKRD37 promoter in HIF1A/ cells, indicating that HIF1A is
largely dispensable for RNAPII recruitment (Figure 4A). Impor-
tantly, hypoxia induces increased RNAPII occupancy in the
gene body and 30 end only in HIF1A+/+ cells. Thus, conversion
of promoter-proximal into elongating RNAPII upon hypoxia
requires HIF1A action. Accordingly, ChIP analysis of S5P and
S2P shows that hypoxia-induced RNAPII phosphorylation at
these key residues is dependent on HIF1A. As predicted from
previous work, hypoxia-induced histone acetylation is strongestBinding or Histone Acetylation
) serine-2-phosphorylated RNAPII CTD (S5P, S2P), (E) HIF1A, (F) H3K9ac, and
protein BRD4, (J) the SEC subunit AFF4, the core Mediator subunits (K) MED1
ANKRD37 locus in control and CDK8 knockdown HCT116 cells in normoxia or
ars represent SEM from three independent biological replicates. Gray shading
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Figure 5. Hypoxia-Inducible Genes Are Active and Paused in Normoxia
(A) Gene profiles showing levels of transcriptionally engaged RNA polymerases (GRO-seq, sense strand) and RNAPII occupancy (ChIP-seq) in comparison to
CDK8 occupancy (ChIP-seq) in normoxia for all RefSeq genes. Heatmap color scales represent the read density for 160 bins across the transcribed region of each
gene with 1 kb upstream and downstream flanking regions (20 bins of 50 bp each). Heatmaps are ranked by gene activity as determined from GRO-seq.
(B) Relative proportions of genes in each transcription class for RefSeq genes (top) and hypoxia-inducible genes (bottom).
(legend continued on next page)
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in HIF1A+/+ cells. In agreement with our hypothesis, HIF1A is also
required for full recruitment of CDK8, the core Mediator subunit
MED1, and CDK9 upon hypoxia.
We next investigated if the transactivation domains (TADs) of
HIF1A could interact with CDK8-Mediator. Toward this end, we
used GST-fusion bait proteins corresponding to the N-TAD,
the C-TAD or a larger region including both TADs and the inter-
vening region (2X-TAD, Figure 4B) to capture interacting factors
from HeLa cell nuclear extracts (Figure 4C). We employed a
GST-VP16 transactivation domain and GST-only baits as posi-
tive and negative controls, respectively. Consistent with previ-
ous studies, the 2X-TAD and C-TAD baits interact with p300
(Kallio et al., 1998). Importantly, the 2X-TAD bait also effectively
pulls down CDK8, additional CDK module subunits (MED12,
MED13, and MED13L), and core Mediator subunits (MED14,
MED15, and MED23). None of these interactions were detected
with the N-TAD and GST-only baits; however, MED12, MED13,
and MED13L were detected using the C-TAD, suggesting that
a region comprising the C-TAD and the intervening region are
required for optimal interaction with CDK8-Mediator. Overall,
we conclude that the transactivation domain of HIF1A can asso-
ciate with CDK8-Mediator, thus providing a physical basis for the
observed HIF1A-dependent recruitment of this coactivator to
hypoxia-inducible target gene loci.
Our gene expression analysis identified HIF1A targets that do
not require CDK8 (e.g., CXCR4, Figures 2A and S4A), as well as
non-hypoxia-inducible genes that do require CDK8 (e.g.,MAGI1,
Figure S4A). ChIP analyses of these genes show that, although
CDK8 depletion does not significantly impair RNAPII activation
or CDK9 recruitment at CXCR4, it does reduce RNAPII phos-
phorylation and CDK9 binding at MAGI1 (Figure S4B). Expect-
edly, analysis of UHMK1, whose expression is not induced by
hypoxia or reduced by CDK8 knockdown, showed no impact
of CDK8 depletion on RNAPII activity (Figures S4A and S4B).
Of note, CXCR4 and UHMK1 carry very low levels of CDK8,
CDK9, and RNAPII (see scales in Figure S4B).
Hypoxia-Inducible Genes Are Active and Paused Prior
to HIF1A Activation
Taken together, our ChIP data so far strongly suggest a require-
ment for CDK8 in stimulating transcription elongation at hypoxia-
inducible HIF1A target genes. Our data are consistent with a
number of genome-wide ChIP studies in which both active and
inactive genes have high levels of RNAPII at their 50 ends
(Guenther et al., 2007; Rahl et al., 2010). However, ChIP analysis
does not distinguish between a buildup of inactive promoter-
bound RNAPII versus transcriptionally competent but paused
RNAPII. In order to better define which step is rate limiting for in-(C) Metagenes showing average GRO-seq (sense strand) and CDK8 ChIP-seq si
hypoxia-inducible genes (red). Units are mean tags per bin for 160 bins across the
regions (20 bins of 50 bp each).
(D) Cumulative distribution plots of pausing index for active RefSeq genes (blue) a
(Kolmogorov-Smirnov test, p = 0.0347).
(E) Cumulative distribution plots of gene activity for active RefSeq genes (blue) an
(Kolmogorov-Smirnov test, p < 0.0001).
(F) Genome browser views showing GRO-seq reads in the sense- (blue) and antis
HIF1A target loci under normoxic conditions.
See also Table S3.duction of these genes, and that might be regulated by CDK8,
we employed global nuclear run-on with deep sequencing
(GRO-seq) to examine the genome-wide location of transcrip-
tionally engaged RNA polymerases in HCT116 cells under nor-
moxic conditions (Core et al., 2008).
As reported previously for other cell types, we observed an
accumulation of transcriptionally engaged RNA polymerases at
the 50 ends of a large fraction of RefSeq genes that corresponds
with the location of RNAPII as defined by ChIP-seq (Figure 5A;
Core et al., 2008; Min et al., 2011; Rahl et al., 2010). Notably,
when ranked by gene activity as measured by GRO-seq read
density in gene bodies, it is clear that those genes with the high-
est levels of promoter-proximal active RNAPII also have sub-
stantial CDK8 enrichment at their 50 end and intragenic regions.
We next classified genes into four classes according to the
GRO-seq read density in both the promoter-proximal region
and the gene body, as in Core et al. (2008): (1) active, not paused;
(2) active, paused; (3) inactive, paused; and (4) inactive, not
paused. We then asked how hypoxia-inducible genes fit within
these classes, which revealed that essentially all of them are
active and paused during normoxia (96%, Figure 5B; Table
S3). Hypergeometric tests show that there is a greater proportion
of hypoxia-inducible genes that are active (p < 2.3 3 1011),
paused (p < 2.2 3 1016), and paused, active (p < 2.2 3 1016)
compared to RefSeq genes. It is also apparent that on average
hypoxia-inducible genes have higher densities of transcription-
ally active RNAPII and CDK8 both at their promoter regions
and within gene bodies than the RefSeq average, even before
HIF1A is activated (Figure 5C). Furthermore, an increased frac-
tion of active hypoxia-inducible genes display higher pausing
indices and higher gene activity relative to all active RefSeq
genes (Figures 5D and 5E). Examples of HIF1A targets that are
both active and paused prior to their induction by hypoxia are
shown in Figure 5F. Overall, these data indicate that pause
release is a rate-limiting step for induction of HIF1A targets.
DISCUSSION
The cellular response to hypoxia is critical for normal physiology
and underlies many disease processes. In particular, induction
of HIF transcription factors due to intratumoral hypoxia
promotes tumorigenesis across several cancer types, likely by
upregulation of angiogenic factors, glucose transporters, and
glycolytic enzymes, as well as prosurvival and invasion factors.
Accordingly, elevated HIF1A expression is associated with
increased mortality in diverse cancers, including those of the
cervix, endometrium, breast, ovary, and colon (Semenza,
2012). Although hundreds of genes across different cell typesgnals across RefSeq genes (blue) in comparison to the average signals across
transcribed region of each gene with 1 kb upstream and downstream flanking
nd active hypoxia-inducible genes (red). Distributions are significantly different
d active hypoxia-inducible genes (red). Distributions are significantly different
ense (red) direction relative to each gene, and RNAPII ChIP-seq signal (gray) at
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Figure 6. A Revised Model of HIF1A
Transactivation
During normoxia, most HIF1A target genes carry
active paused RNAPII. Upon hypoxia, HIF1A
binding to chromatin leads to increased histone
acetylation, recruitment of the bromodomain pro-
tein BRD4, CDK8-Mediator and the SEC contain-
ing P-TEFb, as well as increased RNAPII CTD
phosphorylation and transcriptional elongation. In
the absence of CDK8, HIF1A is able to bind to
chromatin and induce histone acetylation, but fails
to recruit core Mediator and the SEC and is unable
to stimulate transcriptional elongation.have been identified as direct targets of HIF1A and HIF2A, our
knowledge of the mechanisms by which these factors regulate
transcription remains incomplete. Our research described here
has uncovered a HIF1A coactivation mechanism involving the
Mediator subunit CDK8, an oncogene in colorectal cancer (Fire-
stein et al., 2008). These findings constitute a significant advance
in our understanding of how HIF1A regulates transcription, but
also contribute to our view of Mediator in stimulus-specific con-
trol of gene expression and provide a link between HIF1A and
CDK8, two potent oncogenes. Our mechanistic studies lead
to a revised model for HIF1A-dependent transactivation as
depicted in Figure 6.
Prior to HIF1A activation, its target loci carry transcriptionally
engaged, proximally paused RNAPII, indicating that HIF1A
transactivation involves enhanced release from this paused
state. In fact, our global studies of RNAPII behavior demonstrate
that nearly all hypoxia-inducible genes are transcribed and
paused in normoxic conditions. Upon hypoxia, HIF1A binds to
chromatin and enhances histone acetylation and BRD4 recruit-
ment. However, these events alone are not sufficient to stimulate
RNAPII elongation. In addition, HIF1A recruits a variant of
Mediator containing CDK8, MED1, and MED26. Of note, MED1
and MED26 recruitment is impaired upon CDK8 knockdown.
More importantly, CDK8 is required for HIF1A-dependent
recruitment of AFF4, the scaffold subunit of the SEC, and of
CDK9, the catalytic subunit of P-TEFb. This could be due to
the observed defect in MED26 binding, as MED26 has been
shown to interact directly with AFF4 (Takahashi et al., 2011).
Thus, release of paused RNAPII at hypoxia-inducible genes is
driven by a HIF1A > CDK8-Mediator > P-TEFb axis.
Although first reported in Drosophila, it has become apparent
that RNAPII pausing is a conserved feature across many meta-
zoan transcriptional programs (Core and Lis, 2008; Min et al.,
2011; Muse et al., 2007; Rahl et al., 2010; Zeitlinger et al.,
2007). Although our understanding of RNAPII pausing is still
evolving, recent studies lead to a model where pausing is
employed to create transcriptional competence at gene loci acti-
vated in response to developmental cues, cellular stress, and
various other signaling events. In this view, RNAPII pausing is
not a repressive event, but rather a mechanism to protect stim-
ulus-responsive promoters from the negative action of nucleo-
somes (Gilchrist et al., 2010). By preventing promoter occlusion,1336 Cell 153, 1327–1339, June 6, 2013 ª2013 Elsevier Inc.paused RNAPII ensures a basal level of transcription and readies
gene loci for dynamic and synchronous responses to stimuli
(Boettiger and Levine, 2009; Gilchrist et al., 2010). At these
loci, the rate-limiting step is the recruitment of elongation factors,
either directly or indirectly, by stimulus-activated transcription
factors. Thus, RNAPII pausing would confer the hypoxia
response network with a mechanism to induce gene expression
in a robust and timely manner. Interestingly, previous studies
have shown that activated HIF1A binds preferentially to ‘‘permis-
sive’’ loci, and it has been suggested that this may determine the
observed cell-type-specific expression of HIF1A target genes
(Xia and Kung, 2009). Under normoxia, these permissive loci
display preloaded RNAPII, histone methylation marks associ-
ated with active genes and DNase I hypersensitivity. Our data
support and extend these findings by showing that RNAPII is
transcriptionally engaged at virtually all HIF1A target loci in
HCT116 cells prior to hypoxia and that HIF1A is ultimately
required for recruitment of P-TEFb, whose activity is needed to
stimulate RNAPII elongation. Furthermore, the observation that
HIF1A-induced histone acetylation is not sufficient for full
RNAPII activation reinforces the importance of elongation as a
rate-limiting step at HIF1A targets. In fact, earlier work showed
that the HIF1A-binding domain of p300/CBP is dispensable for
transactivation of the majority of HIF1A targets tested, pointing
to the existence of other primary coactivation events (Kasper
et al., 2005). Our results predict that it might be possible to impair
HIF1A function by targeting the biochemical steps leading to
P-TEFb recruitment. Thus, a more detailed characterization of
this pathway, which involves CDK8-Mediator, could reveal ther-
apeutic strategies to attenuate HIF1A-driven pathological
processes.
Since its early discovery as a key regulator of RNAPII activity in
yeast (Koleske et al., 1992; Thompson et al., 1993), Mediator has
proved to be a key player in a myriad of biological processes in
metazoans, including stem cell pluripotency, hormone signaling,
growth factor signaling, and lipid metabolism (Malik and Roeder,
2010). However, the precise molecular mechanism of action of
Mediator remains elusive. Increasingly, Mediator has been
involved in transcription elongation control. Early studies of
Mediator in the serum response network revealed that ablation
of the MED23 subunit abolishes serum-induced gene activation
by a mechanism that could not be explained solely by effects on
RNAPII recruitment (Wang et al., 2005). We later showed that
CDK8 knockdown impairs elongation at serum response genes
(Donner et al., 2010). More recently, the MED26 subunit of Medi-
ator was found to interact directly with the SEC (Takahashi et al.,
2011). Interestingly, biochemical purification experiments sug-
gested that CDK8-containing Mediator is largely devoid of
MED26 and vice versa; however, this subunit segregation is
not absolute and a fraction of Mediator contains both proteins
(Figure 1A; Sato et al., 2004).
Our finding that the HIF1A C-TAD interacts with CDK8-Medi-
ator explains previous studies demonstrating that it has other
transactivation functions beyond association with p300/CBP
(Kasper et al., 2005). It will be interesting to further characterize
the interaction between the HIF1A C-TAD and Mediator
and to define whether the interaction is sensitive to any of
the posttranslational modifications known to affect the trans-
activation potential of HIF1A, such as hydroxylation or
phosphorylation.
In vertebrates, subunits of the CDK module of Mediator have
undergone gene duplication events to generate the paralog pairs
CDK8/CDK19, MED12/MED12L, and MED13/MED13L. These
gene duplications are likely to create additional regulatory diver-
sity in vertebrate cell types (Levine and Tjian, 2003), and there is
evidence that these paralogs are not redundant. CDK8 knockout
mice are embryonic lethal (Westerling et al., 2007), and germline
mutations in CDK19 have been linked to a developmental syn-
drome (Mukhopadhyay et al., 2010). Our results reveal a func-
tional specialization of CDK8 and CDK19 in gene expression
control in colon cancer cells, with the hypoxic response being
a striking example of their nonredundancy. Future studies will
be aimed at defining the molecular basis of this specialization.
Although we have demonstrated here a differential requirement
for the two kinases at hypoxia-inducible genes, it will be impor-
tant to determinewhether this specialization arises fromdifferen-
tial recruitment or by acting on different phosphorylation targets.
Note that the two kinases differ mostly in their C termini, which
could differentially regulate their activity or recruitment to target
gene loci.
Because CDK8, but not CDK19, is commonly amplified in
colorectal cancers (Firestein et al., 2008), it is tempting to spec-
ulate that CDK8 oncogenicity is due to its effects on gene
expression programs not regulated by CDK19. To what extent
can the oncogenic effects of CDK8 overexpression be attributed
to its role as a coactivator of hypoxia-inducible genes?
Answering this question will require a careful genetic dissection
of the hypoxic response versus the various oncogenic pathways
that CDK8 has already been implicated in. CDK8 was first char-
acterized as an oncogene during an unbiased screen for media-
tors of b-catenin-dependent transcription, and CDK8 is also a
positive regulator of genes downstream of growth factor
signaling (Donner et al., 2010; Firestein et al., 2008). More
recently, CDK8 was found to promote the dedifferentiated state
of both colon cancer cells and embryonic stem cells, acting
partly via upregulation of MYC (Adler et al., 2012). Thus, overex-
pression of CDK8 may drive tumor survival and progression by
affecting multiple interconnected pathways, and our work sug-
gests that this may be in part by affecting the HIF1A transcrip-
tional program.EXPERIMENTAL PROCEDURES
Cell Culture
Cells were cultured in McCoy’s 5A, DMEM, RPMI (Sigma), or DMEM/F12 (Life
Technologies) supplemented with 10% fetal bovine serum (Sigma) and antibi-
otic/antimycotic (Life Technologies) under 5% CO2 at 37
C. Cells were plated
24 hr prior to experimental treatments and harvested in RIPA lysis buffer for
protein or either Tri-Reagent (Sigma) or RLT buffer (Qiagen) for total RNA. Hyp-
oxia treatments were carried out in incubation chambers (Billups-Rothenberg)
by flushing twice with 120 l of amixture of 1%O2/5%CO2/94%N2 (Airgas) and
incubated for 24 hr at 37C. 5-Fluorouracil (Sigma) was used at 375 mM.
Glucose deprivation was carried out by dropping glucose concentration
from 4.5 g/l (high) to 1 g/l (low).
HaloTag Pull-Down Assay
Refer to the Extended Experimental Procedures for a detailed protocol. Briefly,
clarified lysates from HCT116 cells transfected with expression plasmids for
HaloTag-CDK8 or -CDK19 were incubated with HaloLink Resin (Promega)
for 15 min at 22C, followed by extensive washing. Interacting proteins were
eluted with SDS elution buffer and analyzed by western blotting.
Chromatin Immunoprecipitation
Chromatin immunoprecipitation was carried out as previously described (Don-
ner et al., 2007, 2010). Antibodies and a detailed protocol are described in the
Extended Experimental Procedures. For ChIP-seq analysis, salmon-sperm
DNA was omitted from the procedure, and an Illumina sequencing library
was prepared from the immunoprecipitated DNA as described in the Extended
Experimental Procedures. For quantitative ChIP analysis of the ANKRD37 and
STC2 loci, real-time PCR was carried out on ChIP-enriched DNA against a
standard curve of input DNA, with amplicons tiling across each locus. Enrich-
ment values for each amplicon were calculated as percentage of the amplicon
with maximum signal for each antibody at each locus. Primers are described in
the Extended Experimental Procedures.
HIF1A-TAD Interaction Assay
Briefly, bait proteins were prepared by expressing GST-HIF1A-TAD and -VP16
fusion proteins, or GST alone, in E. coli strain BL21, and bound to reduced
glutathione Sepharose resin, followed by high- and low-salt washes. Affinity
resins containing each bound GST-bait protein were then incubated with
HeLa nuclear extracts for 3 hr at 4C. The beads were then washed extensively
with buffer containing 0.5M KCl and finally purified proteins eluted with 30mM
reduced glutathione for analysis by western blotting. Refer to the Extended
Experimental Procedures for a detailed protocol.
Microarray, ChIP-Seq, and GRO-Seq Analysis
See the Extended Experimental Procedures.
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